Background Measurement and reporting of quality indicators at the hospital level has been
shown to improve outcomes and support patient choice. Although there are many studies …

Mediastinal lymph node staging in the setting of known or suspected lung cancer is
supported by multiple professional societies as standard for high-quality care, yet proper …

Background There remains debate over the best invasive diagnostic modality for
mediastinal nodal evaluation. Prior studies have limited generalizability and insufficient …

Objectives Invasive mediastinal nodal staging is recommended before curative-intent
resection in patients with non–small cell lung cancer deemed at risk for mediastinal lymph …

Objectives Mediastinal lymph node staging of NSCLC by initial endosonography and
confirmatory mediastinoscopy is recommended by the European guideline. We assessed …

Background The National Comprehensive Cancer Network guidelines recommend surgery
for limited stage small cell lung cancer (SCLC). However, there is no literature on minimum …

Accurate staging improves lung cancer survival by increasing the chances of delivering
stage‐appropriate therapy. However, there is underutilization of, and variability in, the use of …

Background Sampling of≥ 10 lymph nodes during lobectomy for non–small cell lung cancer
(NSCLC) was a previous surveillance metric and potential quality metric of the American …

Accurate mediastinal staging remains a key component in the workup of patients with lung
cancer, since treatment options and prognosis vary depending on the stage. While imaging …

Background Because surgery is rarely recommended, there is minimal literature comparing
the outcomes of surgery and chemoradiation in stage N3 non–small cell lung cancer …